Prostate Cancer Medical Malpractice Lawyer Compensation Claims
Thousands of Canadian citizens are diagnosed with prostate cancer every year. The key to survival is early diagnosis and treatment which is often delayed due to misdiagnosis or misinterpreted test results. Prostate cancer misdiagnosis is extremely common and failure by a healthcare practitioner that amounts to negligence is a matter of medical malpractice and entitles the victim to claim financial recompense for pain and suffering or the loss of opportunity for a cure. Our specialist medical malpractice lawyers deal with prostate cancer clinical negligence cases against doctors, nurses, technicians and other healthcare providers working in medical practices, clinics, hospitals and all other places where health care is dispensed. If you would like advice about prostate cancer misdiagnosis just contact our offices and a specialist medical malpractice lawyer with call to discuss your potential compensation claim without charge and without further obligation. Our medical malpractice lawyers will give you their opinion on the liability of the negligent healthcare provider and will estimate the amount of the likely award of damages there and then.
Prostate Cancer Misdiagnosis Facts
Prostate cancer is the number one cancer diagnosed in Canada in men (aside from skin cancer). It is one of the leading causes of cancer death among men of all ethnicities. About 20,000 men in Canada are diagnosed with prostate cancer each year but only about 3,000 of these die each year. The median age at diagnosis of the disease is 67 years of age and the rate is highest in black men. The median age at death from prostate cancer is 80 years of age. More than twice as many black men die of the disease than in other ethnicities.
Survival rate is dependent upon the stage of the diseased. With those who have localized disease, the five year survival rate is 100 percent. With regional disease, the rate is also 100 percent, even if regional lymph nodes are involved. The survival rate of metastatic disease is only 29 percent but this accounts for only 4 percent of those diagnosed with prostate cancer. The overall survival rate is 99.7 percent and is dependent on a person’s physical health and whether they have slow growing cancer or more aggressive cancer.
Prostate cancer is the third most common cause of death from cancer in all men and the most common cause of cancer death in those over the age of 75 years. Those that are at a higher risk of getting prostate cancer include those who are black, older than 60, have a family history of prostate cancer, have agent orange exposure, abuse alcohol, are farmers, those who eat a lot of animal fat, painters, those who work in tire plants, and those who have been exposed to cadmium. Enlargement of the prostate, on the other hand, does not predispose you to prostate cancer.
The symptoms of prostate cancer include having a delayed stream when urinating, dribbling urine after urination, having a very slow stream, having to strain when voiding or not being able to empty out the urinary bladder, having blood in the urine, having blood in the semen, and having low back and pelvic pain.
The diagnosis of prostate cancer can only be confirmed by having a prostate biopsy. A PSA blood level may or may not be elevated in prostate cancer but, when it is, it is a good test to see if the cancer is coming back. The cancer is graded according to the Gleason score. This grades prostate tumors on a level of 1 to 10. A score of 2-4 is low grade cancer. A score of 5-7 is intermediate grade prostate cancer. A score of 8-10 is high grade or poorly differentiated prostate cancer. A CT scan, MRI scan and bone scan can be done to see the extent of the cancer. Prostate cancer often metastasizes to bone so a bone scan can tell if the cancer is metastatic or not.
There are many treatments for prostate cancer, including not treating it at all. Some cancers are so low grade that the person will die of other diseases before dying from prostate cancer. Other treatments include surgery to remove the prostate gland and radiation to the gland. Prostate cancer is particularly amenable to brachytherapy in which seeds of radiation are inserted into the prostate gland and allowed to deliver high dose radiation to just a small area.
Hormone therapy works for prostate cancer. Hormones like estrogenic medications are given to slow the growth of cancer cells so the cancer doesn’t grow. Chemotherapy doesn’t work as well as radiation but is sometimes used in prostate cancer therapy. Proton beam therapy can shrink cancer cells as well.